PROPHETIRAE

Owner

Goods & Services

Medical analysis services relating to the treatment of persons; medical analysis services for the prediction of response to cancer treatment; medical analysis services for clinical outcomes associated with cancer treatment; medical analysis services for the prediction of side effects of cancer treatment; medical analysis services for the prediction of treatment side effects in a cancer patient; medical analysis services for identification of new drug targets for cancer treatment; medical analysis services for identification of new drug targets for the treatment of cancer drug side effects; medical analysis services for the prediction of response to cancer treatment based on computational analysis of patient's proteins; medical analysis services relating to the treatment of persons for predicting drug side effects based on computational analysis of patient's proteins; medical analysis services relating to the treatment of persons for discovering new drug targets for overcoming cancer drug resistance, based on computational analysis of patient's proteins; medical analysis services for discovering new drug targets for overcoming side effects associated with cancer treatment, based on computational analysis of patient's proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services for the prediction of patients' response to cancer treatment and the identification of associated biological mechanisms; medical analysis services for the prediction of cancer treatment side effects and the identification of associated biological mechanisms.